Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

US Rheumatoid Arthritis Drug Market, Dosage, Price, Sales Insight 2021 - 2026

Published by KuicK Research Product code 989751
Published Content info 300 Pages
Delivery time: 1-2 business days
Price
Back to Top
US Rheumatoid Arthritis Drug Market, Dosage, Price, Sales Insight 2021 - 2026
Published: February 15, 2021 Content info: 300 Pages
Description

"US Rheumatoid Arthritis Drug Market, Dosage, Price, Sales Insight 2021 - 2026" Report Highlights:

  • US Rheumatoid Arthritis Drugs Market & Clinical Trial Insight
  • Comprehensive Insight On Approved Rheumatoid Arthritis Drugs Price & Dosage Analysis For US Market
  • Rheumatoid Arthritis Drugs Patent Timeline
  • Dosage, Formulation, Patent, Pricing Insight by Drug Class
  • 300 Page Data & Analysis On All Approved Drugs In Market

US pharmaceutical market is prepared for the future and relevant challenges in the ever-evolving drug market for rheumatoid arthritis. The glowing business landscape, biopharma companies years ago have discovered significant sources of market opportunities with its novel value creation platform. The US arthritis rheumatoid drug market is data-driven and the available technologies within the country is providing the treasure troves for maximum information with respect to drug development and automation of the clinical trials. The extraordinary tasks performed by the researchers and the novel emerging models available in the US pharmaceutical market are also inclining the entire market towards purposeful work.

Exponentially, the US rheumatoid arthritis drug market is cultivating strengths capable of delivering the patients with best healthcare solution. Being among one of the countries having highest geriatric population, the US researchers from long period of time have been curatively probing all the useful data for transforming the unstructured market into structured one. The normalization of the unstructured data into structured one by accelerating the rheumatoid arthritis research, the country created a novel value of several million dollars by the end of the year 2020. For decades now, large robust clinical fame in the country for the respective disease has made the researchers to discover novel molecules targeting the disease-causing cells and thus opening avenues for further study.

Specifically, in the US there has been a growing mandate for the increased participation of different demographic groups which has eventually help better understand the drugs and their mechanism of action. Hundreds of bio-pharmaceutical companies and med-tech organizations in the US have looked at the emerging technologies and twisted the flexible clinical research activities for luring the next generation. In a short period of time, the market has potentially created more value in terms of size, belief of the patients to live healthy life and ultimately the stakeholders in earning profits by investing more into the development of the market.

As per the "US Rheumatoid Arthritis Drug Market, Dosage, Price, Sales Insight 2021 - 2026" report findings, the major driving operation for the entire market has been the extensive demand of potential medicines in bulk to manifest the challenges and acquire meticulous market paradigm. The US market instead of getting pressurized for delivering effective drugs has been successful in maintaining the compliance as well as integrity of the drug in providing healthcare benefits to the patients. Arrival of smart technologies and many other technological platforms such as artificial intelligence and flexible drug manufacturing processes in the country have been successful in ripping up the old and traditional models for drug development, ultimately leading to unbelievable breakthroughs by the US researchers.

Such change led by the US researchers have made the patients receive the unique advantage of the novel wave of innovation, thus making the future of the market inevitable. The research report, US Rheumatoid Arthritis Drug Market brings together several analyses as well as insight for the country's financial and market status. Based on the overall coverage of the respective market in terms of bio-pharmaceutical and biotech companies, the research report also provides several highlights such as drug sales, research and development spend, country's brand sales and market performance in the past few decades.

Table of Contents

Table of Contents

1. US - Rheumatoid Arthritis Drugs Market Overview

  • 1.1 Current Market Scenario
  • 1.2 Rheumatoid Arthritis Prevalence & Statistics
  • 1.3 US Rheumatoid Arthritis Drugs Clinical Trials Insight

2. US: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) for Rheumatoid Arthritis - Branded & Generic Availability, Dosage, Patent & Price Analysis

  • 2.1 Meloxicam (Mobic)
  • 2.2 Ketoprofen
  • 2.3 Diflunisal
  • 2.4 Fenoprofen
  • 2.5 Flurbiprofen
  • 2.6 Meclofenamate
  • 2.7 Tolmetin
  • 2.8 Etodolac
  • 2.9 Nabumetone (Relafen)
  • 2.10 Indomethacin
  • 2.11 Oxaprozin
  • 2.12 Piroxicam
  • 2.13 Sulindac
  • 2.14 Diclofenac / Misoprostol
  • 2.15 Esomeprazole / Naproxen
  • 2.16 Famotidine / Ibuprofen
  • 2.17 Diclofenac
  • 2.18 Naproxen
  • 2.19 Ibuprofen

3. US: Salisylates Drugs for Rheumatoid Arthritis - Branded & Generic Availability, Dosage, Patent & Price Analysis

  • 3.1 Aspirin
  • 3.2 Salsalate
  • 3.3 Sulfasalazine (Azulfidine)

4. US: Tetracyclines for Rheumatoid Arthritis - Branded & Generic Availability, Dosage, Patent & Price Analysis

  • 4.1 Doxycycline
  • 4.2 Minocycline
  • 4.3 Tetracycline

5. US: Narcotic Analgesic Drugs for Rheumatoid Arthritis - Branded & Generic Availability, Dosage, Patent & Price Analysis

  • 5.1 Acetaminophen / Hydrocodone
  • 5.2 Acetaminophen / Tramadol

6. US: Topical Rubifacient for Rheumatoid Arthritis - Branded & Generic Availability, Dosage, Patent & Price Analysis

  • 6.1 Methyl Salicylate
  • 6.2 Camphor / Menthol / Methyl Salicylate
  • 6.3 Trolamine Salicylate

7. US: Antimetabolites for Rheumatoid Arthritis - Branded & Generic Availability, Dosage & Price Analysis

  • 7.1 Methotrexate

8. US: Glucocorticoides Drugs for Rheumatoid Arthritis - Branded & Generic Availability, Dosage, Patent & Price Analysis

  • 8.1 Prednisone
  • 8.2 Methylprednisolone
  • 8.3 Triamcinolone (Kenalog-40)
  • 8.4 Dexamethasone
  • 8.5 Cortisone

9. US: Quinolines for Rheumatoid Arthritis - Branded & Generic Availability, Dosage & Price Analysis

  • 9.1 Hydroxychloroquine

10. US: Disease-Modifying Antirheumatic Drugs (DMARDs) - Branded & Generic Availability, Dosage, Patent & Price Analysis

  • 10.1 Leflunomide

11. US: TNF Inhibitors - Branded & Generic Availability, Dosage, Patent, Price & Sales Analysis

  • 11.1 Etanercept
  • 11.2 Abatacept

12. US: Monoclonal Antibody - Branded & Biosimilars Availability, Dosage, Patent, Price & Sales Analysis

  • 12.1 Adalimumab
  • 12.2 Tocilizumab
  • 12.3 Infliximab
  • 12.4 Rituximab
  • 12.5 Certolizumab
  • 12.6 Golimumab
  • 12.7 Alemtuzumab
  • 12.8 Sarilumab
  • 12.9 Canakinumab

13. US: Statin - Branded & Generic Availability, Dosage, Patent & Price Analysis

  • 13.1 Atorvastatin

14. US: Immunosuppresants - Branded & Generic Availability, Dosage, Patent & Price Analysis

  • 14.1 Azathioprine
  • 14.2 Anakinra
  • 14.3 Mycophenolate Mofetil

15. US: JAK Inhibitors for Rheumatoid Arthritis - Branded & Generic Availability, Dosage, Price & Sales Analysis

  • 15.1 Tofacitinib (Xeljanz)
  • 15.2 Upadacitinib (Rinvoq)
  • 15.3 Baricitinib (Olumiant)

16. Other Drugs Targeting Rheumatoid Arthritis - Branded & Generic Availability, Dosage, Patent & Price Analysis

  • 16.1 Cyclophosphamide
  • 16.2 Cyclosporine
  • 16.3 Corticotropin
  • 16.4 Penicillamine
  • 16.5 Interferon Gamma-1b (Actimmune)
  • 16.6 Phenytoin

17. Competitive Landscape

  • 17.1 AbbVie
  • 17.2 Bayer
  • 17.3 Bristol Myers Squibb
  • 17.4 Eli Lilly & Company
  • 17.5 Genentech
  • 17.6 Janssen Pharmaceuticals
  • 17.7 Novartis
  • 17.8 Pfizer
  • 17.9 Roche
  • 17.10 Sanofi
  • 17.11 Sun Pharma
  • 17.12 Teva Pharmaceuticals

List of Figures

  • Figure 1-1: US - Risk of Developing Rheumatoid Arthritis by Gender (%)
  • Figure 1-2: US - Rheumatoid Arthritis Market Size (US$), 2020 - 2026
  • Figure 1-3: US - Newly Diagnosed Rheumatoid Arthritis Cases & Total Cases (Million), 2020
  • Figure 1-4: US - Cases of Rheumatoid Arthritis by Gender (Million), 2020
  • Figure 1-5: US - Cases of Rheumatoid Arthritis by Gender (%), 2020
  • Figure 1-6: US - Arthritis Cases by Type (Million), 2020
  • Figure 1-7: US - Arthritis Cases by Type (%), 2020
  • Figure 1-8: US - Estimated Arthritis Cases (Million), 2020, 2025 & 2030
  • Figure 1-9: US - Estimated Rheumatoid Arthritis Cases (Million), 2020, 2025 & 2030
  • Figure 1-10: US - Rheumatoid Arthritis Cases by Age (Million), 2020
  • Figure 1-11: US - Cases of Rheumatoid Arthritis by Age (%), 2020
  • Figure 1-12: US - Number of Rheumatoid Arthritis Drugs Clinical Trials by Phase , 2021 -2025
  • Figure 1-13: US - Number of Rheumatoid Arthritis Drugs Clinical Trials by Drug Class , 2012 -2016
  • Figure 1-14: US - Number of Rheumatoid Arthritis Drugs Clinical Trials by Organization , 2021 - 2026
  • Figure 1-15: US - Number of Rheumatoid Arthritis Drugs Clinical Trials by Formulation , 2021 - 2026
  • Figure 2-1: Mobic- FDA Approval Year by Dosage Form
  • Figure 2-2: Mobic - Price for Various Supplies of 7.5mg Tablet (US$), February'2021
  • Figure 2-3: Mobic - Price for 100 Tablet Supplies & Price Per Unit Tablet of 15mg Tablet (US$), February'2021
  • Figure 2-4: Qmiiz ODT - Price for 100 Tablet Supplies & Price Per Unit Tablet of 7.5mg & 15mg Dose (US$), February'2021
  • Figure 2-5: Generic Meloxicam - Price for Various Supplies of 7.5mg Tablet (US$), February'2021
  • Figure 2-6: Generic Meloxicam - Price for Various Supplies of 15mg Tablet (US$), February'2021
  • Figure 2-7: Meloxicam - Initial & Maintenance Dose (mg/day)
  • Figure 2-8: Ketoprofen - Price for 100 Capsules Supplies & Price Per Unit Capsule of 25mg (US$), February'2021
  • Figure 2-9: Ketoprofen - Price for 100 Capsules Supplies & Price Per Unit Capsule of 50mg (US$), February'2021
  • Figure 2-10: Ketoprofen - Price for 100 Capsules Supplies & Price Per Unit Capsule of 75mg (US$), February'2021
  • Figure 2-11: Ketoprofen ER - Price for 100 Capsule Supplies & Price Per Unit Capsule of 200mg (US$), February'2021
  • Figure 2-12: Ketoprofen - Maximum Daily Dose by Dosage Form (mg/day), February'2021
  • Figure 2-13: Diflunisal - Price for 60 Tablets Supplies & Price Per Unit Tablet of 75mg (US$), February'2021
  • Figure 2-14: Diflunisal - Price for 100 Tablets Supplies & Price Per Unit Tablet of 75mg (US$), February'2021
  • Figure 2-15: Diflunisal - Price for 500 Tablets Supplies & Price Per Unit Tablet of 75mg (US$), February'2021
  • Figure 2-16: Diflunisal - Minimum & Maximum Daily Dose (mg/day), February'2021
  • Figure 2-17: Diflunisal - Average Cost of Minimum & Maximum Daily Dose (US$), February'2021
  • Figure 2-18: Nalfon - Price for 100 Tablets Supplies & Price Per Unit Tablet of 600mg (US$), February'2021
  • Figure 2-19: Generic Fenopofen - Price for 100 Tablets Supplies & Price Per Unit Tablet of 200mg (US$), February'2021
  • Figure 2-20: Generic Fenopofen - Price for 60 Tablets Supplies & Price Per Unit Tablet of 600mg (US$), February'2021
  • Figure 2-21: Generic Fenopofen - Price for 100 Capsules Supplies & Price Per Unit Capsule of 600mg (US$), February'2021
  • Figure 2-22: Fenoprofen - Minimum & Maximum Daily Dose (mg/day), February'2021
  • Figure 2-23: Flubiprofen - Price for 15 Tablets Supplies & Price Per Unit Tablet of 100mg (US$), February'2021
  • Figure 2-24: Flubiprofen - Price for 100 Tablets Supplies & Price Per Unit Tablet of 100mg (US$), February'2021
  • Figure 2-25: Flubiprofen - Price for 500 Tablets Supplies & Price Per Unit Tablet of 100mg (US$), February'2021
  • Figure 2-26: Flurbiprofen - Minimum & Maximum Daily Dose (mg/day), February'2021
  • Figure 2-27: Meclofenamate - Price for 100 Capsules Supplies & Price Per Unit Capsule of 50mg (US$), February'2021
  • Figure 2-28: Meclofenamate - Price for 100 Capsules Supplies & Price Per Unit Capsule of 100mg (US$), February'2021
  • Figure 2-29: Meclofenamate - Minimum & Maximum Daily Dose (mg/day), February'2021
  • Figure 2-30: Meclofenamate - Cost of Minimum & Maximum Daily Dose (US$), February'2021
  • Figure 2-31: Tolmetin - Price for 100 Tablets Supplies & Price Per Unit Tablet of 600mg (US$), February'2021
  • Figure 2-32: Tolmetin - Price for 100 Tablets Supplies & Price Per Unit Tablet of 400mg (US$), February'2021
  • Figure 2-33: Tolmetin - Initial Dose & Maintenance Dose for Rheumatoid Arthritis (mg/ day), February'2021
  • Figure 2-34: Tolmetin - Initial Dose & Maximum Dose for Juvenile Rheumatoid Arthritis (mg/Kg/day), February'2021
  • Figure 2-35: Etodolac Capsules - Price for 100 Capsules Supplies of Various Dose Regimens (US$), February'2021
  • Figure 2-36: Etodolac Tablet - Price for Various Supplies of 400mg (US$), February'2021
  • Figure 2-37: Etodolac Tablet - Price for Various Supplies of 500mg (US$), February'2021
  • Figure 2-38: Etodolac ER Tablet - Price for Various Supplies of 500mg (US$), February'2021
  • Figure 2-39: Etodolac ER Tablet - Price for Various Supplies of 600mg (US$), February'2021
  • Figure 2-40: Etodolac ER Tablet - Price for Various Supplies of 600mg (US$), February'2021
  • Figure 2-41: Etodolac Tablet - Minimum & Maximum Daily Dose (mg/day)
  • Figure 2-42: Etodolac ER Tablet - Minimum & Maximum Daily Dose (mg/day)
  • Figure 2-43: Etodolac Tablet - Minimum & Maximum Daily Dose for Juvenile Rheumatoid Arthritis by Body Weight (mg/day)
  • Figure 2-44: Relafen - Price for 30 Tablet Supply & Price Per Unit Tablet of 750mg Dose (US$), February'2021
  • Figure 2-45: Relafen DS - Price for 30 Tablet Supply & Price Per Unit Tablet of 1000mg Dose (US$), February'2021
  • Figure 2-46: Relafen DS - Price for 60 Tablet Supply & Price Per Unit Tablet of 1000mg Dose (US$), February'2021
  • Figure 2-47: Generic Nabumetone - Price for Various Supplies of 500mg Dose (US$), February'2021
  • Figure 2-48: Generic Nabumetone - Price for Various Supplies of 750mg Dose (US$), February'2021
  • Figure 2-49: Nabumetone - Initial Dose & Maintenance Dose (mg//day), February'2021
  • Figure 2-50: US - Tivorbex Patent Issue & Expiration Year
  • Figure 2-51: Indocin - Price for 237ml Supply & Price Per ml of 25mg/5ml Oral Suspension (US$), February'2021
  • Figure 2-52: Indocin - Price for 30 Suppositories & Price Per Unit of 50mg Suppository (US$), February'2021
  • Figure 2-53: Tivorbex - Price for 30 Capsules & Price Per Unit of 20mg Capsules (US$), February'2021
  • Figure 2-54: Generic Indomethacin - Price for 6 Capsules & Price Per Unit of 25mg Capsules (US$), February'2021
  • Figure 2-55: Generic Indomethacin - Price for 20 Capsules & Price Per Unit of 50mg Capsules (US$), February'2021
  • Figure 2-56: Generic Indomethacin ER - Price for 30 Capsules & Price Per Unit of 75mg Capsules (US$), February'2021
  • Figure 2-57: Generic Indomethacin ER - Price for 100 Capsules & Price Per Unit of 75mg Capsules (US$), February'2021
  • Figure 2-58: Indomethacin Oral - Initial & Maximum Dose (mg/day)
  • Figure 2-59: Indomethacin Suppository - Initial & Maintenence Dose (mg/day)
  • Figure 2-60: Daypro - Price for Various Supplies of 600mg Tablet (US$), February'2021
  • Figure 2-61: Generic Oxaprozin - Price for Various Supplies of 600mg Tablet (US$), February'2021
  • Figure 2-62: Generic Oxaprozin - Minimum & Maximum Adult Dose (mg/day)
  • Figure 2-63: Generic Oxaprozin - Pediatric Dose by Body Weight (mg/day)
  • Figure 2-64: Feldene - FDA Approval & First Generic Approval Year
  • Figure 2-65: Feldene - Price for 100 Capsules Supply of Various Dose Regimens (US$), February'2021
  • Figure 2-66: Generic Piroxicam - Price for 100 Capsules Supply of Various Dose Regimens (US$), February'2021
  • Figure 2-67: Generic Piroxicam - Price for 500 Capsules Supply & Price Per Unit of 20mg Capsules (US$), February'2021
  • Figure 2-68: Sulindac - Price for Various Supplies of 150mg Tablets (US$), February'2021
  • Figure 2-69: Sulindac - Price for Various Supplies of 200mg Tablets (US$), February'2021
  • Figure 2-70: Sulindac - Initial & Maximum Dose (mg/day)
  • Figure 2-71: Sulindac - Initial & Maximum Daily Treatment Cost (US$), February'2021
  • Figure 2-72: Arthrotec - FDA Approval & First Generic Approval Year
  • Figure 2-73: Arthrotec - Price for Various Supplies of 50mg-200mg Tablets (US$), February'2021
  • Figure 2-74: Arthrotec - Price for 60 Tablets Supply & Price Per Unit of 75mg-200mg Tablets (US$), February'2021
  • Figure 2-75: Generic Arthrotec - Price for Various Supplies of 50mg-200mg Tablets (US$), February'2021
  • Figure 2-76: Generic Arthrotec - Price for 60 Tablets Supply & Price Per Unit of 75mg-200mg Tablets (US$), February'2021
  • Figure 2-77: Arthrotec - Minimum & Maximum Daily Treatment Cost (US$), February'2021
  • Figure 2-78: US - Vimovo Patent Issue & Expiration Year
  • Figure 2-79: Vimovo - Price for 60 Tablets Supply of Various Dose Regimens (US$), February'2021
  • Figure 2-80: Generic Vimovo - Price for 60 Tablets Supply of Various Dose Regimens (US$), February'2021
  • Figure 2-81: Vimovo - Daily Treatment Cost Using Generic & Branded Tablet (US$), February'2021
  • Figure 2-82: US - Duexis Patent Issue & Expiration Year
  • Figure 2-83: Duexis - Price for 90 Tablet Supply & Price Per Unit Tablet (US$), February'2021
  • Figure 2-84: Diclofenac Capsules - Price for 90 Capsules Supply & Price Per Unit Capsules of 35mg (US$), February'2021
  • Figure 2-85: Diclofenac Delayed Release Tablet - Price For 100 Tablets of 25mg (US$), February'2021
  • Figure 2-86: Diclofenac Delayed Release Tablet - Price for Various Supplies of 50mg (US$), February'2021
  • Figure 2-87: Diclofenac Delayed Release Tablet - Price for Various Supplies of 75mg (US$), February'2021
  • Figure 2-88: Catafalm - Price for Various Supplies of Oral Tablet 25mg (US$), February'2021
  • Figure 2-89: Generic Catafalm - Price for Various Supplies of Oral Tablet 25mg (US$), February'2021
  • Figure 2-90: Naprosyn - FDA Approval & First Generic Approval Year
  • Figure 2-91: Naprosyn - Price for 473ml Supply & Price per ml of Oral Suspension (US$), February'2021
  • Figure 2-92: Generic Naprosyn - Price for 473ml Supply & Price per ml of Oral Suspension (US$), February'2021
  • Figure 2-93: Aleve - Price for Various Supplies of 220mg Capsule (US$), February'2021
  • Figure 2-94: Generic Aleve Capsules - Price for Various Supplies of 220mg Capsule (US$), February'2021
  • Figure 2-95: Generic Aleve Tablets - Price for Various Supplies of 220mg Tablet (US$), February'2021
  • Figure 2-96: EC-Naprosyn - FDA Approval & First Generic Approval Year
  • Figure 2-97: EC-Naprosyn - Price for Various Supplies of 375mg Tablet (US$), February'2021
  • Figure 2-98: EC-Naprosyn - Price for Various Supplies of 500mg Tablet (US$), February'2021
  • Figure 2-99: Naprelan - FDA Approval & First Generic Approval Year
  • Figure 2-100: Naprelan - Price for 100 Tablets Supply & Price Per Unit of 375mg Tablet (US$), February'2021
  • Figure 2-101: Naprelan - Price for 30 Tablets Supply & Price Per Unit of 500mg Tablet (US$), February'2021
  • Figure 2-102: Generic Naprelan - Price for 100 Tablets Supply & Price Per Unit of 375mg Tablet (US$), February'2021
  • Figure 2-103: Generic Naprelan - Price for 75 Tablets Supply & Price Per Unit of 500mg Tablet (US$), February'2021
  • Figure 2-104: Naproxen Immediate Release Tablet - Minimum & Maximum Daily Dose (mg/day)
  • Figure 2-105: Advil - Price for Various Supplies of 200mg Oral Tablet (US$), February'2021
  • Figure 2-106: Advil Liqui-Gels - Price for 20 Capsules Supply & Price Per Unit Capsule of 200mg (US$), February'2021
  • Figure 2-107: Advil Children's - Price for 120ml Supply & Price per ml of Oral Suspension (US$), February'2021
  • Figure 2-108: Mortin IB - Price for 20 Capsules Supply & Price Per Unit Capsule of 200mg (US$), February'2021
  • Figure 2-109: Mortin IB - Price for Various Supplies of 200mg Tablet (US$), February'2021
  • Figure 2-110: Children's Mortin - Price for 24 Tablets Supply & Price Per Unit Tablet of 100mg (US$), February'2021
  • Figure 2-111: Neoprofene - FDA Approval & First Generic Approval Year
  • Figure 2-112: US - Neoprofene Patent Issue & Expiration Year
  • Figure 2-113: Neoprofene - Price for 6ml Supply & Price Per ml of Intravenous Solution (US$), February'2021
  • Figure 2-114: Motrin Childrens - Price for 120ml Supply & Price Per ml of Oral Suspension (US$), February'2021
  • Figure 2-115: Motrin Childrens - Price for 240ml Supply & Price Per ml of Oral Suspension (US$), February'2021
  • Figure 2-116: US - Caldolor Patent Issue & Expiration Year
  • Figure 2-117: Caldolor - Price for 200ml Supply & Price Per ml of 100mg/ml Intravenous Solution (US$), February'2021
  • Figure 2-118: Caldolor - Price for 400ml Supply & Price Per ml of 800mg/200ml Intravenous Solution (US$), February'2021
  • Figure 2-119: Generic Ibuprofen - Price for 6ml Supply & Price Per ml of 10mg/ml Intravenous Solution (US$), February'2021
  • Figure 2-120: Generic Ibuprofen - Price for 20 Capsules & Price Per Unit of 200mg Capsules (US$), February'2021
  • Figure 2-121: Generic Ibuprofen - Price for 15ml Supply & Price Per ml of 50mg/1.25ml Oral Suspension (US$), February'2021
  • Figure 2-122: Generic Ibuprofen - Price for 150ml Supply & Price Per ml of 100mg/5ml Oral Suspension (US$), February'2021
  • Figure 2-123: Generic Ibuprofen - Price for 24 Tablets Supply & Price Per Unit of 200mg (US$), February'2021
  • Figure 2-124: Generic Ibuprofen - Price for 6 Tablets Supply & Price Per Unit of 400mg (US$), February'2021
  • Figure 2-125: Generic Ibuprofen - Price for 4 Tablets Supply of 600mg & 800mg Tablets (US$), February'2021
  • Figure 2-126: Generic Ibuprofen - Price for 24 Tablets Supply & Price Per Unit of 100mg Chewable Tablet (US$), February'2021
  • Figure 2-127: Ibuprofen - Minimum & Maximum Daily Dose (US$), February'2021
  • Figure 3-1: Bayer Aspirin - Price for Various Supplies of 325mg Tablets (US$), February'2021
  • Figure 3-2: Ecpirin - Price for Various Supplies of 325mg Delayed Release Tablets (US$), February'2021
  • Figure 3-3: Generic Aspirin - Price for Various Supplies of 81mg Delayed Release Tablets (US$), February'2021
  • Figure 3-4: Generic Aspirin - Price for 100 Tablet Supply & Price Per Unit 325mg Delayed Release Tablets (US$), February'2021
  • Figure 3-5: Generic Aspirin - Price for 50 Tablet Supply & Price Per Unit 325mg Tablets (US$), February'2021
  • Figure 3-6: Generic Aspirin - Price for Various Supplies of 325mg Chewable Tablets (US$), February'2021
  • Figure 3-7: Generic Aspirin - Price for 12 Suppositories Supply of Various Dose Regimen (US$), February'2021
  • Figure 3-8: Salsalate - Price for Various Supplies of 500mg Tablets (US$), February'2021
  • Figure 3-9: Salsalate - Price for Various Supplies of 750mg Tablets (US$), February'2021
  • Figure 3-10: Sulfasalazine - FDA Approval Year by Product
  • Figure 3-11: Azulfidine - Price for Various Supplies of 500mg Tablets (US$), February'2021
  • Figure 3-12: Azulfidine EN - Price for Various Supplies of 500mg Tablets (US$), February'2021
  • Figure 3-13: Generic Azulfidine EN - Price for Various Supplies of 500mg Tablets (US$), February'2021
  • Figure 3-14: Generic Azulfidine - Price for Various Supplies of 500mg Tablets (US$), February'2021
  • Figure 3-15: Salfasalazine - Minimum & Maximum Daily Dose (mg/day)
  • Figure 4-1: US - Patent Approval & Expiration Year by Mayne Pharmaceuticals
  • Figure 4-2: US - Patent Approval & Expiration Year by Galderma Laboratories
  • Figure 4-3: US - Patent Approval & Expiration Year by TCD Royalty
  • Figure 4-4: Doxocycline - Cost of 10 & per Unit Cost of Injectable Powder (US$), February'2021
  • Figure 4-5: Doxocycline - Cost of 16, 30, 50, 60 & 100 Hyclate 50mg (US$), February'2021
  • Figure 4-6: Doxocycline - Cost of 50 & 100 Monohydrate 50mg (US$), February'2021
  • Figure 4-7: Doxocycline - Cost of 60 & 100 Monohydrate 75mg (US$), February'2021
  • Figure 4-8: Doxocycline - Cost of 60 Capsule by Strength (US$), February'2021
  • Figure 4-9: Doxycycline - Costs of Supply of 30 Tablets & per Unit Price of Oral Delayed Release Capsule (US$), February'21
  • Figure 4-10: Doxycycline - Costs of Supply of 60 Tablets by Strength (US$), February'21
  • Figure 4-11: Doxycycline - Costs of Supply of 120 Tablets & per Unit Price of Hyclate 50mg Tablet (US$), February'21
  • Figure 4-12: Doxycycline - Costs of Supply of 100 Tablets & per Unit Price of Hyclate 100mg Tablet (US$), February'21
  • Figure 4-13: US - Patent Approval & Expiration Year by Medicis Pharmaceutical Crop
  • Figure 4-14: US - Patent Approval & Expiration Year by Melinta Therapeutics
  • Figure 4-15: US - Patent Approval & Expiration Year by Ora Pharma
  • Figure 4-16: US - Patent Approval & Expiration Year by Vyne Pharmaceuticals
  • Figure 4-17: Minocycline - Cost of Supply of 30, 60 & 100 Capsules of 50mg (US$), February'2021
  • Figure 4-18: Minocycline - Cost of Supply of 100 Capsules & per Unit Cost of 75mg Capsule (US$), February'2021
  • Figure 4-19: Minocycline - Cost of Supply of 14, 20, 30, 50, 60 & 500 Capsules of 75mg Capsule (US$), February'2021
  • Figure 4-20: Minocycline - Cost of Supply of 90 & 100 Tablets of 50mg (US$), February'2021
  • Figure 4-21: Minocycline - Cost of Supply of 100 Capsules & per Unit Cost of 75mg Tablet (US$), February'2021
  • Figure 4-22: Minocycline - Cost of Supply of 50 & 60 Tablets of 100mg (US$), February'2021
  • Figure 4-23: Minocycline - Cost of Supply of 30 Tablets of 45mg, 55mg, 65mg & 80mg OraL Tablets (US$), February'2021
  • Figure 4-24: Minocycline - Cost of Supply of 30 Tablets of 90mg, 105mg, 115mg & 135mg OraL Tablets (US$), February'2021
  • Figure 4-25: Minocycline - Recommended Capsule Strength by Weight (mg)
  • Figure 4-26: US - Tetracycline Patent Approval & Expiration Year
  • Figure 4-27: Tetracycline - Cost of Supply of 100 & per Unit Price of 250mg Tablet (US$), February'2021
  • Figure 4-28: Tetracycline - Cost of Supply of 100 & per Unit Price of 500mg Tablet (US$), February'2021
  • Figure 5-1: Norco - Price for 100 Tablets Supply of Various Dose Regimens (US$), February'2021
  • Figure 5-2: Norco - Price for 500 Tablets Supply & Price Per Unit of 325mg-10mg Tablet (US$), February'2021
  • Figure 5-3: Lortab - Price for 473ml Supply & Price Per ml of Oral Liquid (US$), February'2021
  • Figure 5-4: Generic Acetaminophen/hydrocodone - Price for Various Supplies of 108mg-2.5mg/5ml Oral Liquid (US$), February'2021
  • Figure 5-5: Generic Acetaminophen/hydrocodone - Price for Various Supplies of 108mg-217mg-5mg/10ml Oral Liquid (US$), February'2021
  • Figure 5-6: Generic Acetaminophen/hydrocodone - Price for 118ml Supply & Price Per ml of 325mg-7.5mg/15ml Oral Solution (US$), February'2021
  • Figure 5-7: Generic Acetaminophen/hydrocodone - Price for 120ml Supply & Price Per ml of 325mg-10mg/15ml Oral Solution (US$), February'2021
  • Figure 5-8: Generic Acetaminophen/hydrocodone - Price for 100 Tablets Supply of Various Dose Regimen (US$), February'2021
  • Figure 5-9: Ultracet - FDA Approval & First Generic Approval Year
  • Figure 5-10: Ultracet - Price for 100 Tablets Supply & Price Per Unit of 325mg-37.5mg Tablets (US$), February'2021
  • Figure 5-11: Generic Ultracet - Price for Various Supplies of 325mg-37.5mg Tablets (US$), February'2021
  • Figure 6-1: Mentholatum Deep Heating - Price for 60ml Supply & Price Per Unit of Topical Lotion (US$), February'2021
  • Figure 6-2: Generic Methyl Salicylate - Price for 60ml Supply & Price Per Unit of Topical Oil (US$), February'2021
  • Figure 6-3: Camphor/Menthol/Methyl Salicylate Cream - Price for 57 Gram Generic & Branded Cream (US$), February'2021
  • Figure 6-4: Trolamine salicylate - FDA Approval Year by Brand
  • Figure 6-5: Mobisyl Cream - Price for Various Supplies of 10% Cream (US$), February'2021
  • Figure 6-6: Arthricream - Price for Various Supplies of 10% Cream (US$), February'2021
  • Figure 7-1: US - FDA Methotrexate Approval Year
  • Figure 7-2: Methotrexate - Cost of Supply of Intravenous Solution by Brand (US$), February'2021
  • Figure 7-3: Trexall - Cost of Supply of 30 Tablets by Strength (US$), February'2021
  • Figure 7-4: Methotrexate - per Unit Cost of Intravenous Powder & Solution (US$), February-2021
  • Figure 7-5: Methotrexate - Cost of 20, 30, 36 & 100 Oral Tablets (US$), February'2021
  • Figure 7-6: Methotrexate - Maximum & Minimum Recommended Dose (mg/week)
  • Figure 8-1: US - Prednisone Patent Approval & Expiration Year
  • Figure 8-2: Rayos - Cost of Supply of 30 Tablets & per Unit Price of Tablet (US$), February'21
  • Figure 8-3: Prednisone - Cost of Supply of 30ml, 120ml & 500ml Oral Solution (US$), February'2021
  • Figure 8-4: Prednisone - Cost of Supply of 100 Tablets by Strength (US$), February'2021
  • Figure 8-5: Prednisone - Recommended Maximum & Minimum Dose (mg/day)
  • Figure 8-6: Medrol- Cost of Supply of 100 Tablets by Strength (US$), February'2021
  • Figure 8-7: Medrol - Cost of Supply of 25 Tablets by Strength (US$), February'2021
  • Figure 8-8: Medrol - per Unit Cost of Tablet by Strength (US$), February'2021
  • Figure 8-9: Medrol Dosepak - Cost of Supply of 21 Tablets & per Unit price of 4mg Oral Tablet (US$), February'2021
  • Figure 8-10: Depo-Medrol - per Unit Cost of Intravenous Solution by Strength (US$), February'2021
  • Figure 8-11: SoluMedrol - Cost of Supply of Injectable Powder by Strength (US$), February'2021
  • Figure 8-12: SoluMedrol - Cost of Preservative Free Injectable Powder by Strength (US$), February'2021
  • Figure 8-13: Methylprednisolone - Cost of 1 unit Injectable Powder by Strength (US$), February'2021
  • Figure 8-14: Methyprednisolone - Cost of 40mg/ml Injectable Suspension by Strength (US$), February'2021
  • Figure 8-15: Methyprednisolone - Cost of 80mg/ml Injectable Suspension by Strength (US$), February'2021
  • Figure 8-16: Methylprednisolone - per Unit Price of Oral Tablet by Strength (US$), February'2021
  • Figure 8-17: Kenalovg-40 - Price for a Supply of 1ml, 5ml & 10ml Suspension for Injection (US$), February'2021
  • Figure 8-18: Triamcinolone - Price for a Supply of 1ml, 5ml, 10ml & 25ml Suspension for Injection (US$), February'2021
  • Figure 8-19: Kenalog-40 - Minimum & Maximum Dose (mg/day), February'2021
  • Figure 8-20: Kenalog-40 - Initial & Maintenance Dose in Systemic Administration (mg/day), February'2021
  • Figure 8-21: Kenalog-40 - Minimum & Maximum Dose in Local Administration (mg/day), February'2021
  • Figure 8-22: Dexamethasone - Cost of Supply of 24ml, 25ml, 30ml, 125ml & 750ml of 4mg/ml Solution (US$), February'2021
  • Figure 8-23: Dexamethasone - Cost of Supply of 24ml & 25ml of 10mg/ml Preservative Free Solution (US$), February'2021
  • Figure 8-24: Dexamethasone - Cost of Supply of 24ml & 25ml of 10mg/ml Solution (US$), February'2021
  • Figure 8-25: Dexamethasone - Cost of Supply of 237ml, 240ml & 500ml Oral Liquid (US$), February'21
  • Figure 8-26: Dexamethasone - Cost of Supply of 100 Tablets by Strength (US$), February'2021
  • Figure 8-27: Dexamthasone - Recommended Maximum & Minimum Dose by Disease
  • Figure 8-28: Cortisone - Cost of Supply of 100 Tablets & per Unit Price (US$), February'2021
  • Figure 8-29: Cortisone - Recommended Maximum & Minimum Dose (mg/day)
  • Figure 9-1: Plaquenil - Cost of Supply of 100 Tablets & per Unit Price of 200mg Tablets (US$), February'2021
  • Figure 9-2: Hydroxychloroquine - Cost of Supply of 50, 100 & 500 Tablets (US$), February'21
  • Figure 9-3: Hydroxychloroquine - Maximum & Minimum Recommended Dose (mg)
  • Figure 9-4: Hydroxychloroquine - Recommended Dose (Tablet)
  • Figure 10-1: US - Leflunomide FDA Approval & Generic Approval Year
  • Figure 10-2: Arava - Cost of Supply of 30 Tablets & Per Unit Price (US$), February'2021
  • Figure 10-3: Leflunomide - Cost of Supply of 30, 50 & 1000 Oral 10mg Tablets (US$), February'2021
  • Figure 10-4: Leflunomide - Cost of Supply of 30, 50 & 1000 Oral 20mg Tablets (US$), February'2021
  • Figure 10-5: Price Differential of Generic & Braned Oral Tablet by Strength (US$)
  • Figure 10-6: Leflunomide - Recommended Dose (mg/day) by Phase
  • Figure 10-7: Leflunomide - Recommended Initial Dose & Reduced Dose (mg/day)
  • Figure 11-1: US - Etanercept Patent Approval & Expiration Year
  • Figure 11-2: US - FDA Approval History of Branded Drugs & Biosimilars
  • Figure 11-3: Etanercept - Cost of Supply of 4 Kits & Per Unit Price (US$), February'2021
  • Figure 11-4: Etanercept - Cost of Supply of 2ml & Per Unit Price of 25mg/0.5ml Solution (US$), February'2021
  • Figure 11-5: Etanercept - Cost of Supply of 4ml & Per Unit Price of 50mg/ml Solution (US$), February'2021
  • Figure 11-6: Etanercept - Cost of Single Cycle, Monthly & Annual Cost by Subcutaneous Kit (US$)
  • Figure 11-7: Etanercept - Cost of Single Cycle, Monthly & Annual Cost by 25mg/0.5ml Subcutaneous Solution (US$)
  • Figure 11-8: Etanercept - Cost of Single Cycle, Monthly & Annual Cost by 50mg/ml Subcutaneous Solution (US$)
  • Figure 11-9: Global - Enbrel Annual Sales (US$ Millions), 2017-2020
  • Figure 11-10: Global - Enbrel Quaterly Sales (US$ Millions), 2019
  • Figure 11-11: US - Enbrel Quaterly Sales (US$ Millions), 2019
  • Figure 11-12: Enbrel - Annual Sales by Region (%), 2019
  • Figure 11-13: Global - Enbrel Quaterly Sales (US$ Millions), 2020
  • Figure 11-14: US - Enbrel Quaterly Sales (US$ Millions), 2020
  • Figure 11-15: Enbrel - Annual Sales by Region (US$ Million), 2020
  • Figure 11-16: Enbrel - Annual Sales by Region (%), 2020
  • Figure 11-17: Abatacept - FDA Approval History by Type
  • Figure 11-18: Abatacept - Recommended Dose by Weight (mg)
  • Figure 11-19: Abatacept - Required Number of Vials by Weight
  • Figure 11-20: Abatacept - Average Cost per Cycle by Weight (US$)
  • Figure 11-21: Global - Abatacept Annual Sales (US$ Million), 2017-2020
  • Figure 11-22: US - Abatacept Annual Sales (US$ Million), 2017-2020
  • Figure 11-23: Global - Abatacept Quarterly Sales (US$ Million), 2019 & 2020
  • Figure 11-24: US - Abatacept Quarterly Sales (US$ Million), 2019 & 2020
  • Figure 11-25: Abatacept - Annual Sales by Region (%), 2020
  • Figure 12-1: US - FDA Approval History of Humira & Biosimilar Drugs
  • Figure 12-2: Humira - Cost of Supply of 2 Kit & Per Unit price (US$), February'2021
  • Figure 12-3: Humira - Maximum & Minimum Recommended Dose (mg/week)
  • Figure 12-4: Global - Humira Annual Sales (US$ Million), 2018-2020
  • Figure 12-5: US - Humira Annual Sales (US$ Million), 2018-2020
  • Figure 12-6: Global - Humira Quarterly Sales (US$ Million), 2019 & 2020
  • Figure 12-7: US - Humira Quarterly Sales (US$ Million), 2019 & 2020
  • Figure 12-8: Humira - Annual Sales by Region (%), 2020
  • Figure 12-9: Tocilizumab - Cost of Supply of 20ml, 10ml, 4ml & 1ml Intravenous Solution (US$), February'2021
  • Figure 12-10: Tocilizumab - Cost of Supply of 0.9ml &1ml Subcutaneous Solution (US$), February'2021
  • Figure 12-11: Tocilizumab - Recommended Maximum & Minimum Dose of Intravenous Solution (mg/kg)
  • Figure 12-12: Global - Tocilizumab Annual Sales (US$ Million), 2017-2019
  • Figure 12-13: US - Tocilizumab Annual Sales (US$ Million), 2017-2019
  • Figure 12-14: US - Tocilizumab Quarterly Sales (US$ Million), 2020
  • Figure 12-15: Tocilizumab - Annual Sales by Region (US$ Million), 2020
  • Figure 12-16: Tocilizumab - Annual Sales by Region (%), 2020
  • Figure 12-17: Remicade - FDA Approval History for Branded & Biosimilars
  • Figure 12-18: Price Differential of Branded & Biosimilars Intraveous Powder (US$), February'2021
  • Figure 12-19: Remicade - Recommended Maximm & Minimum Dose (mg/kg)
  • Figure 12-20: Global - Inflectra Quarterly Sales (US$ Million), 2018 & 2019
  • Figure 12-21: US - Inflectra Quarterly Sales (US$ Million), 2018 & 2019
  • Figure 12-22: Inflectra - Annual Sales by Region (%), 2019
  • Figure 12-23: Global - Inflectra Quarterly Sales (US$ Million), 2020
  • Figure 12-24: US - Inflectra Quarterly Sales (US$ Million), 2020
  • Figure 12-25: Inflectra - Annual Sales by Region (%), 2020
  • Figure 12-26: Global - Inflectra Annual Sales (US$ Million), 2018-2020
  • Figure 12-27: US - Rituximab, Truxima & Ruxience Approval Year
  • Figure 12-28: Rituximab - Cost of Supply of 10ml, 50ml & 100ml Intravenous Solution (US$), February'2021
  • Figure 12-29: Truxima - Cost of Supply of 10ml & 50ml Intravenous Solution (US$), February'2021
  • Figure 12-30: Ruxience - Cost of Supply of 10ml & 50ml Intravenous Solution (US$), February'2021
  • Figure 12-31: Average Cost of Per Unit Supply of Rituximab, Truxima & Ruxience (US$), February'2021
  • Figure 12-32: Riabni - Cost of Supply of 10mg & 500mg Intravenous Solution (US$)
  • Figure 12-33: Global - Rituximab Annual Sales (US$ Million), 2017-2020
  • Figure 12-34: US - Rituximab Annual Sales (US$ Million), 2017-2020
  • Figure 12-35: Rituximab - Annual Sales by Region (%), 2019
  • Figure 12-36: Rituximab - Annual Sales by Region (%), 2020
  • Figure 12-37: US - Certolizumab FDA Approval & Patent Exclusivity Year
  • Figure 12-38: Certolizumab - Cost of Single Cycle & Annual Cost of Treatment (US$)
  • Figure 12-39: Global - Cimzia Annual Sales (US$ Million), 2017-2019
  • Figure 12-40: US - Cimzia Annual Sales (US$ Million), 2017-2019
  • Figure 12-41: Cimzia - Annual Sales by Region (US$ Million), 2019
  • Figure 12-42: Cimzia - Annual Sales by Region (%), 2019
  • Figure 12-43: Global - Cimzia Half Yearly Sales (US$ Million), 2016-2019
  • Figure 12-44: US - Cimzia Half Yearly Sales (US$ Million), 2016-2019
  • Figure 12-45: Cimzia - Half Yearly Sales by Region (%), 2020
  • Figure 12-46: US - FDA Approval History by Brand
  • Figure 12-47: Simponi - Cost of Supply of 0.5ml & 1ml Subcutaneous Solution, February'2021
  • Figure 12-48: Simponi Aria - Cost of Supply of 4ml & 1ml Subcutaneous Solution (US$), February'2021
  • Figure 12-49: Recommended Dose by Drug Type (mg/month)
  • Figure 12-50: Global - Gloimumab Annual Sales (US$ Million), 2017-2019
  • Figure 12-51: US - Gloimumab Annual Sales (US$ Million), 2017-2019
  • Figure 12-52: Global - Golimumab Quarterly Sales (US$ Million), 2019 & 2020
  • Figure 12-53: US - Golimumab Quarterly Sales (US$ Million), 2019 & 2020
  • Figure 12-54: Golimumab - Annual Sales by Region (%), 2020
  • Figure 12-55: US - Alemtuzumab FDA Approval & Patent Exclusivity Year
  • Figure 12-56: Alemtuzumab - Cost of 1.2ml & 1ml Intravenous Solution (US4), February'2021
  • Figure 12-57: Sarilumab - Cost of Supply of 2.8ml & 1ml Intravenous Solution, February'2021
  • Figure 12-58: Sarilumab - Recommended Initial Dose & Reduced Dose (mg)
  • Figure 12-59: Global - Sarilumab Annual Sales (US$ Million), 2017-2020
  • Figure 12-60: US - Sarilumab Annual Sales (US$ Million), 2017-2019
  • Figure 12-61: Global - Sarilumab Quarterly Sales (US$ Million), 2019 & 2020
  • Figure 12-62: US - Sarilumab Quarterly Sales (US$ Million), 2019 & 2020
  • Figure 12-63: US - Canakinumab FDA Approval & Patent Exclusivity Year
  • Figure 12-64: Canakinumab - Maximum & Minimum Recoomended Dose (mg)
  • Figure 12-65: Canakinumab - Maximum & Minimum Cost of Cycle (US$)
  • Figure 12-66: Global - Ilaris Annual Sales (US$ Million), 2018-2020
  • Figure 13-1: US - Atorvastatin Patent Approval & Expiration Year
  • Figure 13-2: Lipitor - Cost of Supply of 30, 90 & 100 Oral 10mg Tablets (US$), February'2021
  • Figure 13-3: Lipitor - Cost of Supply of 30, 90 & 100 Oral 20mg & 40mg Tablets (US$), February'2021
  • Figure 13-4: Lipitor - Cost of Supply of 64, 90 & 500 Oral 80mg Tablets (US$), February'2021
  • Figure 13-5: Atorvastatin - Cost of Supply of 30, 90 & 100 Oral 10mg Tablets (US$), February'2021
  • Figure 13-6: Atorvastatin - Cost of Supply of 30, 90 & 100 Oral 20mg Tablets (US$), February'2021
  • Figure 13-7: Atorvastatin - Cost of Supply of 30, 90 & 100 Oral 40mg Tablets (US$), February'2021
  • Figure 13-8: Atorvastatin - Cost of Supply of 30, 90 & 100 Oral 80mg Tablets (US$), February'2021
  • Figure 13-9: Price Differential of Branded & Generic Drug (US$)
  • Figure 14-1: Azasan - Cost of Supply of 100 Tablets & Per Unit Price of 75mg Tablet (US$), February'2021
  • Figure 14-2: Azasan - Cost of Supply of 100 Tablets &
  • Figure 14-3: Imuran - Cost of Supply of 100 Tablets & Per Unit Price of 50mg Tablet (US$), February'2021
  • Figure 14-4: Azathioprine - Cost of Supply of 30, 50, 100 & 500 Tablets (US$), February'2021
  • Figure 14-5: Azathioprine - Minimum & Maximum Recommended Dose (mg/kg)
  • Figure 14-6: US - Anakinra FDA Approval & Patent Exclusivity Year
  • Figure 14-7: Anakinra - Cost of 4.69ml & 1ml of Intravenous Solution (US$), February'2021
  • Figure 14-8: Anakinra - Cost of 18.76ml & 1ml of Intravenous Solution (US$), February'2021
  • Figure 14-9: Anakinra - Average Cost of Single Cycle, Monthly & Annual Cost of Treatment (US$)
  • Figure 14-10: US - Cellcept Patent Approval & Expiration Year
  • Figure 14-11: Cellcept - Cost of 4 Intravenous Powder & Unit Cost Oral Powder (US$), February'2021
  • Figure 14-12: Cellcept - Cost of 160ml Powder & Unit Cost Oral Powder (US$), February'2021
  • Figure 14-13: Cellcept - Cost of 100 & 500 Oral Capsules (US$), February'2021
  • Figure 14-14: Cellcept - Cost of 100 & 500 Oral Tablets (US$), February'2021
  • Figure 14-15: Mycophenolate Mofetil - Cost of 4 Intravenous Powder & Unit Cost Oral Powder (US$), February'2021
  • Figure 14-16: Mycophenolate Mofetil - Cost of 160ml & 250ml Oral Powder (US$), February'2021
  • Figure 14-17: Mycophenolate Mofetil - Cost of 100, 500 & 1440 Oral Capsules (US$), February'2021
  • Figure 14-18: Mycophenolate Mofetil - Cost of 100 & 500 Oral Tablets (US$), February'2021
  • Figure 14-19: Price Differential of Branded & Generic Drug (US$)
  • Figure 15-1: US - Xeljenz Patent Issue & Expiration Year
  • Figure 15-2: Xeljenz - Price for 60 Tablets & Price Per Unit Tablet of 5mg & 10mg (US$), February'2021
  • Figure 15-3: Xeljenz - Price for 30 Tablets & Price per unit Tablet of 22mg (US$), February'2021
  • Figure 15-4: Xeljenz Tablet - Initial & Reduced Dose for Rheumatic Arthritis (mg/day), February'2021
  • Figure 15-5: Xeljenz Extended Tablet - Initial & Reduced Dose for Rheumatic Arthritis (mg/day), February'2021
  • Figure 15-6: Global - Xeljenz Sales Value (US$ Billion), 2017 - 2020
  • Figure 15-7: US - Xeljenz Sales Value (US$ Million), 2017 - 2020
  • Figure 15-8: Global - Xeljenz Sales Value by Region (US$ Million), 2020
  • Figure 15-9: Global - Xeljenz Sales Value by Region (%), 2020
  • Figure 15-10: Global - Xeljenz Quarterly Sales Value (US$ Million), 2019 & 2020
  • Figure 15-11: US - Xeljenz Quarterly Sales Value (US$ Million), 2019 & 2020
  • Figure 15-12: US - Rinvoq Patent Issue & Expiration Year
  • Figure 15-13: Rinvoq - Price for 30 Tablets & Price Per Unit Tablet of 15mg (US$), February'2021
  • Figure 15-14: Global - Rinvoq Sales Value (US$ Million), 2019 & 2020
  • Figure 15-15: US - Rinvoq Sales Value (US$ Million), 2019 & 2020
  • Figure 15-16: Global - Rinvoq Sales Value by Region (US$ Million), 2020
  • Figure 15-17: Global - Rinvoq Sales Value by Region (%), 2020
  • Figure 15-18: Global - Rinvoq Quarterly Sales Value (US$ Million), 2020
  • Figure 15-19: US - Rinvoq Quarterly Sales Value (US$ Million), 2020
  • Figure 15-20: US - Olumiant Patent Issue & Expiration Year
  • Figure 15-21: Olumiant - Price for 30 Tablets & Price Per Unit Tablet of 1mg & 2mg (US$), February'2021
  • Figure 15-22: Global - Olumiant Sales Value (US$ Billion), 2019 & 2020
  • Figure 15-23: US - Olumiant Sales Value (US$ Million), 2019 & 2020
  • Figure 15-24: Global - Olumiant Sales Value by Region (US$ Million), 2020
  • Figure 15-25: Global - Olumiant Sales Value by Region (%), 2020
  • Figure 15-26: Global - Olumiant Quarterly Sales Value (US$ Million), 2019 & 2020
  • Figure 16-1: Cyclophosphamide - Price for Various Supplies of intravenous Powder for Injection (US$), February'2021
  • Figure 16-2: Cyclophosphamide - Price for various Supplies of 200mg/ml intravenous Solution for Injection (US$), February'2021
  • Figure 16-3: Cyclophosphamide - Price for 100 Capsule Supply of 25mg & 50mg Dose (US$), February'2021
  • Figure 16-4: Cyclophosphamide - Minimum & Maximum Dose as Single Agent (mg/Kg), February'2021
  • Figure 16-5: Sandiummune - FDA Approval Year by Dosage Form
  • Figure 16-6: Sandiummune - First Generic FDA Approval Year by Dosage Form
  • Figure 16-7: Sandimmune - Price for 50ml & Price Per ml of Injectable Solution (US$), February'2021
  • Figure 16-8: Sandimmune - Price for 50ml & Price Per ml of Oral Solution (US$), February'2021
  • Figure 16-9: Sandimmune Capsules - Price for 30 Capsules of Various Dose Regimens (US$), February'2021
  • Figure 16-10: Neoral - FDA & First Generic Approval Year
  • Figure 16-11: Neoral - Price for 50ml & Price per ml of Oral Solution (US$), February'2021
  • Figure 16-12: Neoral Capsules - Price for 30 Capsules of Various Dose Regimens (US$), February'2021
  • Figure 16-13: Gengraf - Price for 50ml & Price per ml of Oral Solution (US$), February'2021
  • Figure 16-14: Gengraf Capsules - Price for 30 Capsules of Various Dose Regimens (US$), February'2021
  • Figure 16-15: Generic Sandimmune - Price for 50ml & Price per ml of Oral Solution (US$), February'2021
  • Figure 16-16: Generic Sandimmune Capsules - Price for 30 Capsules of Various Dose Regimens (US$), February'2021
  • Figure 16-17: Generic Neoral Capsules - Price for 30 Capsules of Various Dose Regimens (US$), February'2021
  • Figure 16-18: Cyclosporin - Recommended Initial & Maximum Dose (mg/Kg/day), February'2021
  • Figure 16-19: H.P. Acthar Gel - Price for 5ml & Price Per ml of Injectable Solution (US$), February'2021
  • Figure 16-20: H.P. Acthar Gel - Minimum & Maximum Dose (Units Once Every 2 to 3 Days)
  • Figure 16-21: Penicillamine - FDA Approval Year by Brand Name
  • Figure 16-22: Cuprimine - Price for 100 Capsules Supply & Price Per Unit Capsule (US$), February'2021
  • Figure 16-23: Depen - Price for 100 Tablets Supply & Price Per Unit Tablet (US$), February'2021
  • Figure 16-24: Generic Penicillamine Capsule - Price for 100 Capsules Supply & Price Per Unit Capsule (US$), February'2021
  • Figure 16-25: Generic Penicillamine Tablet - Price for 100 Tablets Supply & Price Per Unit Tablet (US$), February'2021
  • Figure 16-26: Penicillamine - Minimum & Maximum Initial Dose (mg/day)
  • Figure 16-27: Penicillamine - Minimum & Maximum Maintenance Dose (mg/day)
  • Figure 16-28: Actimmune - FDA Approval & Patent Expiration Year
  • Figure 16-29: Actimmune - Price for 6ml Supply, 1 ml & Price for Single Vial of 0.5ml Subcutaneous Solution (US$), February'2021
  • Figure 16-30: Phenytoin - Price for Various Supplies of Oral Suspension (US$), February'2021
  • Figure 16-31: Phenytoin - Price for Various Supplies of Oral Chewable Tablet (US$), February'2021
Back to Top